1 – 30 of 30
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Intensive care in children with non-Hodgkin lymphoma in Sweden
2024) In Acta Paediatrica, International Journal of Paediatrics(
- Contribution to journal › Article
-
Mark
Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
(
- Contribution to journal › Article
- 2023
-
Mark
The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols
(
- Contribution to journal › Article
-
Mark
The Prognostic Effect of IKZF1 Deletions in ETV6:: RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
-
Mark
Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old with Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial
(
- Contribution to journal › Article
-
Mark
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2022
-
Mark
High need for intensive care in paediatric acute myeloid leukaemia : A population-based study
(
- Contribution to journal › Article
-
Mark
Long-Term Risk of Hospitalization for Somatic Diseases among Survivors of Childhood Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
-
Mark
Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden : A population-based cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Skeletal adverse events in childhood cancer survivors : An Adult Life after Childhood Cancer in Scandinavia cohort study
(
- Contribution to journal › Article
-
Mark
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2018
-
Mark
Late mortality and morbidity among long-term leukemia survivors with Down syndrome : A nationwide population-based cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebellar mutism syndrome in children with brain tumours of the posterior fossa
(
- Contribution to journal › Article
- 2016
-
Mark
Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
(
- Contribution to journal › Article
- 2015
-
Mark
Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
(
- Contribution to journal › Article
-
Mark
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
(
- Contribution to journal › Article
- 2014
-
Mark
Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
(
- Contribution to journal › Article
-
Mark
23 läkare om omskärelse av små pojkar : Läkarförbundet bör inta en mer odmjuk hållning
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells
(
- Contribution to journal › Article
- 2012
-
Mark
Homozygous deletions of CDKN2A are present in all dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation
(
- Contribution to journal › Letter
- 2011
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
- 2009
-
Mark
Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All
(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: Rare T-cell receptor gene rearrangements are associated with poor outcome.
(
- Contribution to journal › Article
- 2008
-
Mark
Array-CGH reveals hidden gene dose changes in children with acute lymphoblastic leukaemia and a normal or failed karyotype by G-banding
(
- Contribution to journal › Article
-
Mark
Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival
(
- Contribution to journal › Article
-
Mark
Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-Cell precursor acute lymphoblastic leukemias: A nordic series of 24 cases and review of the literature
(
- Contribution to journal › Scientific review